PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxa2
|
ENSMUSG00000037025.12 | Foxa2 |
Foxa1
|
ENSMUSG00000035451.8 | Foxa1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxa2 | mm39_v1_chr2_-_147888816_147888912 | 0.84 | 1.8e-20 | Click! |
Foxa1 | mm39_v1_chr12_-_57592907_57592926 | 0.73 | 2.2e-13 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_104623505 | 52.90 |
ENSMUST00000031663.10
ENSMUST00000065072.7 |
C8b
|
complement component 8, beta polypeptide |
chr5_-_87054796 | 43.62 |
ENSMUST00000031181.16
ENSMUST00000113333.2 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr12_+_8027640 | 38.12 |
ENSMUST00000171271.8
ENSMUST00000037811.13 |
Apob
|
apolipoprotein B |
chr12_+_8027767 | 37.46 |
ENSMUST00000037520.14
|
Apob
|
apolipoprotein B |
chr16_+_22710785 | 33.61 |
ENSMUST00000023583.7
ENSMUST00000232098.2 |
Ahsg
|
alpha-2-HS-glycoprotein |
chr15_+_54274151 | 32.31 |
ENSMUST00000036737.4
|
Colec10
|
collectin sub-family member 10 |
chr4_-_57916283 | 31.61 |
ENSMUST00000063816.6
|
D630039A03Rik
|
RIKEN cDNA D630039A03 gene |
chr8_-_45747883 | 31.36 |
ENSMUST00000026907.6
|
Klkb1
|
kallikrein B, plasma 1 |
chr15_-_96929086 | 31.05 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chrX_+_100419965 | 30.71 |
ENSMUST00000119080.8
|
Gjb1
|
gap junction protein, beta 1 |
chr9_+_46179899 | 30.20 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr16_+_17149235 | 29.87 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr13_+_4099001 | 28.61 |
ENSMUST00000118717.10
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr12_-_103623418 | 28.30 |
ENSMUST00000044159.7
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr5_-_89605622 | 27.03 |
ENSMUST00000049209.13
|
Gc
|
vitamin D binding protein |
chr17_+_12597490 | 26.92 |
ENSMUST00000014578.7
|
Plg
|
plasminogen |
chr16_-_38115172 | 26.64 |
ENSMUST00000023504.5
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr1_-_130589349 | 24.61 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr11_-_100036792 | 24.50 |
ENSMUST00000007317.8
|
Krt19
|
keratin 19 |
chr17_-_31363245 | 24.16 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr17_+_25097199 | 23.39 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr1_-_130589321 | 22.70 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr4_-_6275629 | 21.98 |
ENSMUST00000029905.2
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr12_-_81014849 | 21.60 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr6_-_23132977 | 21.42 |
ENSMUST00000031707.14
|
Aass
|
aminoadipate-semialdehyde synthase |
chr5_-_90788323 | 21.11 |
ENSMUST00000202784.4
ENSMUST00000031317.10 ENSMUST00000201370.2 |
Rassf6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr15_-_96918203 | 21.05 |
ENSMUST00000166223.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr9_-_99599312 | 20.60 |
ENSMUST00000112882.9
ENSMUST00000131922.2 |
Cldn18
|
claudin 18 |
chr17_-_31383976 | 19.72 |
ENSMUST00000235870.2
|
Tff1
|
trefoil factor 1 |
chr15_-_96917804 | 19.59 |
ENSMUST00000231039.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr11_+_96820220 | 19.37 |
ENSMUST00000062172.6
|
Prr15l
|
proline rich 15-like |
chr11_+_96820091 | 19.32 |
ENSMUST00000054311.6
ENSMUST00000107636.4 |
Prr15l
|
proline rich 15-like |
chr12_-_103871146 | 19.32 |
ENSMUST00000074051.6
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr8_-_45715049 | 19.23 |
ENSMUST00000034064.5
|
F11
|
coagulation factor XI |
chr9_-_99592116 | 18.96 |
ENSMUST00000035048.12
|
Cldn18
|
claudin 18 |
chr8_-_62576140 | 18.87 |
ENSMUST00000034052.14
ENSMUST00000034054.9 |
Anxa10
|
annexin A10 |
chr9_-_99592058 | 18.32 |
ENSMUST00000136429.8
|
Cldn18
|
claudin 18 |
chr12_-_81014755 | 17.79 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr7_-_105249308 | 17.35 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr15_+_10224052 | 16.23 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr7_+_100966289 | 16.16 |
ENSMUST00000163799.9
ENSMUST00000164479.9 |
Stard10
|
START domain containing 10 |
chr9_+_46139878 | 15.71 |
ENSMUST00000034588.9
ENSMUST00000132155.2 |
Apoa1
|
apolipoprotein A-I |
chr8_-_65582206 | 15.39 |
ENSMUST00000098713.5
|
Smim31
|
small integral membrane protein 31 |
chr2_-_62313981 | 15.35 |
ENSMUST00000136686.2
ENSMUST00000102733.10 |
Gcg
|
glucagon |
chr6_+_34686543 | 15.06 |
ENSMUST00000031775.13
|
Cald1
|
caldesmon 1 |
chr5_-_115109118 | 14.87 |
ENSMUST00000031535.12
|
Hnf1a
|
HNF1 homeobox A |
chr6_+_34686373 | 14.66 |
ENSMUST00000115021.8
|
Cald1
|
caldesmon 1 |
chr6_-_86742789 | 14.35 |
ENSMUST00000123732.4
|
Anxa4
|
annexin A4 |
chr5_-_90788460 | 14.27 |
ENSMUST00000202704.4
|
Rassf6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr9_+_37450551 | 13.91 |
ENSMUST00000002008.7
ENSMUST00000215957.2 ENSMUST00000215271.2 |
Vsig2
|
V-set and immunoglobulin domain containing 2 |
chr6_+_146934082 | 13.74 |
ENSMUST00000036194.6
|
Rep15
|
RAB15 effector protein |
chr4_-_63072367 | 13.11 |
ENSMUST00000030041.5
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr9_+_44951075 | 13.08 |
ENSMUST00000217097.2
|
Mpzl2
|
myelin protein zero-like 2 |
chr10_-_61814852 | 12.91 |
ENSMUST00000105453.8
ENSMUST00000105452.9 ENSMUST00000105454.3 |
Col13a1
|
collagen, type XIII, alpha 1 |
chr1_+_67162176 | 12.91 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr17_-_12894716 | 12.78 |
ENSMUST00000024596.10
|
Slc22a1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr3_+_69129745 | 12.67 |
ENSMUST00000183126.2
|
Arl14
|
ADP-ribosylation factor-like 14 |
chr3_-_146302343 | 12.64 |
ENSMUST00000029836.9
|
Dnase2b
|
deoxyribonuclease II beta |
chr17_+_48037758 | 12.56 |
ENSMUST00000024782.12
ENSMUST00000144955.2 |
Pgc
|
progastricsin (pepsinogen C) |
chr7_+_140343652 | 12.34 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr7_+_45370607 | 12.25 |
ENSMUST00000129507.5
|
Fam83e
|
family with sequence similarity 83, member E |
chr14_-_52151537 | 12.16 |
ENSMUST00000227402.2
ENSMUST00000227237.2 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr4_+_150938376 | 12.06 |
ENSMUST00000073600.9
|
Errfi1
|
ERBB receptor feedback inhibitor 1 |
chr3_-_144738526 | 11.96 |
ENSMUST00000029919.7
|
Clca1
|
chloride channel accessory 1 |
chr6_-_86742847 | 11.81 |
ENSMUST00000113675.8
|
Anxa4
|
annexin A4 |
chr6_-_83633064 | 11.81 |
ENSMUST00000014686.3
|
Clec4f
|
C-type lectin domain family 4, member f |
chr10_+_115653152 | 11.65 |
ENSMUST00000080630.11
ENSMUST00000179196.3 ENSMUST00000035563.15 |
Tspan8
|
tetraspanin 8 |
chr8_+_107329983 | 11.49 |
ENSMUST00000000312.12
ENSMUST00000167688.2 |
Cdh1
|
cadherin 1 |
chr12_-_103739847 | 11.46 |
ENSMUST00000078869.6
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr15_+_4756684 | 11.39 |
ENSMUST00000161997.8
ENSMUST00000022788.15 |
C6
|
complement component 6 |
chr14_-_30665232 | 11.19 |
ENSMUST00000006704.17
ENSMUST00000163118.2 |
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr6_+_87350292 | 11.10 |
ENSMUST00000032128.6
|
Gkn2
|
gastrokine 2 |
chr11_-_59927688 | 10.97 |
ENSMUST00000102692.10
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr2_-_134396268 | 10.92 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chrX_+_149377416 | 10.68 |
ENSMUST00000112713.3
|
Pfkfb1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr6_+_15185202 | 10.62 |
ENSMUST00000154448.2
|
Foxp2
|
forkhead box P2 |
chr19_+_56414114 | 10.45 |
ENSMUST00000238892.2
|
Casp7
|
caspase 7 |
chr6_-_87365859 | 10.44 |
ENSMUST00000032127.6
|
Gkn3
|
gastrokine 3 |
chr12_-_103829810 | 10.43 |
ENSMUST00000085056.8
ENSMUST00000072876.12 ENSMUST00000124717.2 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr5_-_66238313 | 10.42 |
ENSMUST00000202700.4
ENSMUST00000094757.9 ENSMUST00000113724.6 |
Rbm47
|
RNA binding motif protein 47 |
chr12_-_103704417 | 10.42 |
ENSMUST00000095450.11
ENSMUST00000187220.2 |
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr2_-_60552980 | 10.36 |
ENSMUST00000028348.9
ENSMUST00000112517.8 |
Itgb6
|
integrin beta 6 |
chr18_+_36797113 | 10.28 |
ENSMUST00000036765.8
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr15_+_4756657 | 10.27 |
ENSMUST00000162585.8
|
C6
|
complement component 6 |
chr9_-_107546195 | 10.20 |
ENSMUST00000192990.6
|
Slc38a3
|
solute carrier family 38, member 3 |
chr12_+_112645237 | 10.17 |
ENSMUST00000174780.2
ENSMUST00000169593.2 ENSMUST00000173942.2 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr11_+_78389913 | 10.11 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr9_-_107546166 | 9.99 |
ENSMUST00000177567.8
|
Slc38a3
|
solute carrier family 38, member 3 |
chr5_+_16758897 | 9.89 |
ENSMUST00000196645.2
|
Hgf
|
hepatocyte growth factor |
chr9_-_44714263 | 9.87 |
ENSMUST00000044694.8
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr11_+_69983459 | 9.83 |
ENSMUST00000102572.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr5_+_16758777 | 9.66 |
ENSMUST00000030683.8
|
Hgf
|
hepatocyte growth factor |
chr3_+_129326004 | 9.52 |
ENSMUST00000199910.5
ENSMUST00000197070.5 ENSMUST00000071402.7 |
Elovl6
|
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
chr10_-_78554104 | 9.36 |
ENSMUST00000005488.9
|
Casp14
|
caspase 14 |
chr11_+_69983531 | 9.15 |
ENSMUST00000124721.2
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr1_+_157353696 | 9.08 |
ENSMUST00000111700.8
|
Sec16b
|
SEC16 homolog B (S. cerevisiae) |
chr7_+_130633776 | 9.00 |
ENSMUST00000084509.7
ENSMUST00000213064.3 ENSMUST00000208311.4 |
Dmbt1
|
deleted in malignant brain tumors 1 |
chr3_+_20011405 | 8.96 |
ENSMUST00000108325.9
|
Cp
|
ceruloplasmin |
chr11_+_69983479 | 8.81 |
ENSMUST00000143772.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr10_+_23727325 | 8.70 |
ENSMUST00000020190.8
|
Vnn3
|
vanin 3 |
chr10_+_111342147 | 8.63 |
ENSMUST00000164773.2
|
Phlda1
|
pleckstrin homology like domain, family A, member 1 |
chr3_+_129326285 | 8.63 |
ENSMUST00000197235.5
|
Elovl6
|
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
chr14_-_40907106 | 8.42 |
ENSMUST00000077136.5
|
Sftpd
|
surfactant associated protein D |
chr1_-_136888118 | 8.37 |
ENSMUST00000192357.6
ENSMUST00000027649.14 |
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr11_-_99328969 | 8.23 |
ENSMUST00000017743.3
|
Krt20
|
keratin 20 |
chr2_+_24235300 | 8.12 |
ENSMUST00000114485.9
ENSMUST00000114482.3 |
Il1rn
|
interleukin 1 receptor antagonist |
chr2_+_58645189 | 8.11 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr16_-_48232770 | 8.09 |
ENSMUST00000212197.2
|
Gm5485
|
predicted gene 5485 |
chr3_+_122277372 | 8.03 |
ENSMUST00000197073.2
|
Bcar3
|
breast cancer anti-estrogen resistance 3 |
chr13_+_23991010 | 8.02 |
ENSMUST00000006786.11
ENSMUST00000099697.3 |
Slc17a2
|
solute carrier family 17 (sodium phosphate), member 2 |
chr6_+_14901343 | 8.02 |
ENSMUST00000115477.8
|
Foxp2
|
forkhead box P2 |
chr11_+_94455865 | 7.99 |
ENSMUST00000040418.9
|
Chad
|
chondroadherin |
chr12_-_103623354 | 7.99 |
ENSMUST00000152517.2
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr10_+_87697155 | 7.86 |
ENSMUST00000122100.3
|
Igf1
|
insulin-like growth factor 1 |
chr5_+_16758538 | 7.84 |
ENSMUST00000199581.5
|
Hgf
|
hepatocyte growth factor |
chr19_-_40175709 | 7.68 |
ENSMUST00000051846.13
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr15_+_102012782 | 7.45 |
ENSMUST00000230474.2
|
Tns2
|
tensin 2 |
chr2_+_58644922 | 7.30 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr6_-_3494587 | 7.18 |
ENSMUST00000049985.15
|
Hepacam2
|
HEPACAM family member 2 |
chr12_-_76842263 | 7.14 |
ENSMUST00000082431.6
|
Gpx2
|
glutathione peroxidase 2 |
chr14_+_73475335 | 7.09 |
ENSMUST00000044405.8
|
Lpar6
|
lysophosphatidic acid receptor 6 |
chr4_+_133788065 | 6.95 |
ENSMUST00000227683.2
|
Crybg2
|
crystallin beta-gamma domain containing 2 |
chr19_+_44980565 | 6.89 |
ENSMUST00000179305.2
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr13_+_41013230 | 6.86 |
ENSMUST00000110191.10
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
chr14_-_20319242 | 6.77 |
ENSMUST00000024155.9
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr3_-_92922976 | 6.71 |
ENSMUST00000107301.2
ENSMUST00000029521.5 |
Crct1
|
cysteine-rich C-terminal 1 |
chr3_-_131138541 | 6.69 |
ENSMUST00000090246.5
ENSMUST00000126569.2 |
Sgms2
|
sphingomyelin synthase 2 |
chr3_+_20011251 | 6.68 |
ENSMUST00000108328.8
|
Cp
|
ceruloplasmin |
chr2_-_104573179 | 6.66 |
ENSMUST00000028595.8
|
Depdc7
|
DEP domain containing 7 |
chr12_-_32000169 | 6.61 |
ENSMUST00000176520.8
|
Hbp1
|
high mobility group box transcription factor 1 |
chr17_-_31852128 | 6.43 |
ENSMUST00000236909.2
|
Cbs
|
cystathionine beta-synthase |
chr12_+_119407145 | 6.28 |
ENSMUST00000048880.7
|
Macc1
|
metastasis associated in colon cancer 1 |
chr4_+_43401232 | 6.27 |
ENSMUST00000125399.2
|
Rusc2
|
RUN and SH3 domain containing 2 |
chr3_+_20011201 | 6.25 |
ENSMUST00000091309.12
ENSMUST00000108329.8 ENSMUST00000003714.13 |
Cp
|
ceruloplasmin |
chr2_+_158148413 | 6.21 |
ENSMUST00000109491.8
ENSMUST00000016168.9 |
Lbp
|
lipopolysaccharide binding protein |
chr13_-_60324755 | 6.18 |
ENSMUST00000223933.2
|
Gas1
|
growth arrest specific 1 |
chr5_+_90708962 | 6.13 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chr14_+_40853734 | 6.11 |
ENSMUST00000022314.10
ENSMUST00000170719.2 |
Sftpa1
|
surfactant associated protein A1 |
chr4_-_103072343 | 5.93 |
ENSMUST00000150285.8
|
Slc35d1
|
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
chr6_+_15184630 | 5.92 |
ENSMUST00000115470.3
|
Foxp2
|
forkhead box P2 |
chr4_+_144619696 | 5.92 |
ENSMUST00000142808.8
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr15_-_3333003 | 5.90 |
ENSMUST00000165386.2
|
Ccdc152
|
coiled-coil domain containing 152 |
chr5_-_18093739 | 5.89 |
ENSMUST00000169095.6
ENSMUST00000197574.2 |
Cd36
|
CD36 molecule |
chr3_+_106393348 | 5.84 |
ENSMUST00000183271.2
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr5_-_66309244 | 5.83 |
ENSMUST00000167950.8
|
Rbm47
|
RNA binding motif protein 47 |
chr8_+_68729219 | 5.83 |
ENSMUST00000066594.4
|
Sh2d4a
|
SH2 domain containing 4A |
chr18_+_51250748 | 5.67 |
ENSMUST00000116639.4
|
Prr16
|
proline rich 16 |
chr4_-_127247864 | 5.46 |
ENSMUST00000106090.8
ENSMUST00000060419.2 |
Gjb4
|
gap junction protein, beta 4 |
chr15_+_10177709 | 5.44 |
ENSMUST00000124470.8
|
Prlr
|
prolactin receptor |
chr1_+_93301596 | 5.38 |
ENSMUST00000058682.11
ENSMUST00000186641.7 |
Ano7
|
anoctamin 7 |
chr6_+_129510331 | 5.31 |
ENSMUST00000204956.2
ENSMUST00000204639.2 |
Gabarapl1
|
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
chr12_-_32000209 | 5.29 |
ENSMUST00000176084.2
ENSMUST00000176103.8 ENSMUST00000167458.9 |
Hbp1
|
high mobility group box transcription factor 1 |
chr11_+_115714853 | 5.27 |
ENSMUST00000103032.11
ENSMUST00000133250.8 ENSMUST00000177736.8 |
Llgl2
|
LLGL2 scribble cell polarity complex component |
chr13_-_100753419 | 5.23 |
ENSMUST00000168772.2
ENSMUST00000163163.9 ENSMUST00000022137.14 |
Marveld2
|
MARVEL (membrane-associating) domain containing 2 |
chr2_+_154042291 | 5.04 |
ENSMUST00000028987.7
|
Bpifb1
|
BPI fold containing family B, member 1 |
chr6_+_129510145 | 5.03 |
ENSMUST00000204487.3
|
Gabarapl1
|
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
chr6_+_14901439 | 5.02 |
ENSMUST00000128567.8
|
Foxp2
|
forkhead box P2 |
chr4_+_144619647 | 4.99 |
ENSMUST00000154208.8
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr13_-_60325170 | 4.99 |
ENSMUST00000065086.6
|
Gas1
|
growth arrest specific 1 |
chr11_-_75816717 | 4.94 |
ENSMUST00000021208.11
|
Rph3al
|
rabphilin 3A-like (without C2 domains) |
chr18_+_70058533 | 4.77 |
ENSMUST00000043929.11
|
Ccdc68
|
coiled-coil domain containing 68 |
chr5_-_66211842 | 4.75 |
ENSMUST00000200852.4
|
Rbm47
|
RNA binding motif protein 47 |
chr11_-_46581135 | 4.68 |
ENSMUST00000169584.8
|
Timd2
|
T cell immunoglobulin and mucin domain containing 2 |
chr3_-_113166153 | 4.64 |
ENSMUST00000098673.5
|
Amy2a5
|
amylase 2a5 |
chr11_+_115225557 | 4.58 |
ENSMUST00000106543.8
ENSMUST00000019006.5 |
Otop3
|
otopetrin 3 |
chrX_+_108138965 | 4.55 |
ENSMUST00000033598.9
|
Sh3bgrl
|
SH3-binding domain glutamic acid-rich protein like |
chr3_-_30194559 | 4.55 |
ENSMUST00000108271.10
|
Mecom
|
MDS1 and EVI1 complex locus |
chr15_-_101833160 | 4.45 |
ENSMUST00000023797.8
|
Krt4
|
keratin 4 |
chr16_-_88360037 | 4.45 |
ENSMUST00000049697.5
|
Cldn8
|
claudin 8 |
chr1_+_40619215 | 4.44 |
ENSMUST00000027233.9
|
Slc9a4
|
solute carrier family 9 (sodium/hydrogen exchanger), member 4 |
chr4_+_148686985 | 4.43 |
ENSMUST00000105701.9
ENSMUST00000052060.7 |
Masp2
|
mannan-binding lectin serine peptidase 2 |
chr19_-_58443593 | 4.41 |
ENSMUST00000135730.2
ENSMUST00000152507.8 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr18_+_70058613 | 4.34 |
ENSMUST00000080050.6
|
Ccdc68
|
coiled-coil domain containing 68 |
chr6_-_52135261 | 4.30 |
ENSMUST00000000964.6
ENSMUST00000120363.2 |
Hoxa1
|
homeobox A1 |
chr11_-_68277799 | 4.28 |
ENSMUST00000135141.2
|
Ntn1
|
netrin 1 |
chr7_-_84328553 | 4.28 |
ENSMUST00000069537.3
ENSMUST00000207865.2 ENSMUST00000178385.9 ENSMUST00000208782.2 |
Zfand6
|
zinc finger, AN1-type domain 6 |
chr5_+_43673093 | 4.24 |
ENSMUST00000144558.3
|
C1qtnf7
|
C1q and tumor necrosis factor related protein 7 |
chrX_-_144131890 | 4.20 |
ENSMUST00000040084.10
ENSMUST00000123443.2 |
Lhfpl1
|
lipoma HMGIC fusion partner-like 1 |
chr11_-_49603501 | 4.20 |
ENSMUST00000020624.7
ENSMUST00000145353.8 |
Cnot6
|
CCR4-NOT transcription complex, subunit 6 |
chr3_-_20329823 | 4.19 |
ENSMUST00000011607.6
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr19_-_9065309 | 4.16 |
ENSMUST00000025554.3
|
Scgb1a1
|
secretoglobin, family 1A, member 1 (uteroglobin) |
chr7_-_80053063 | 4.10 |
ENSMUST00000147150.2
|
Furin
|
furin (paired basic amino acid cleaving enzyme) |
chr10_-_95678748 | 4.06 |
ENSMUST00000210336.2
|
Gm33543
|
predicted gene, 33543 |
chr16_+_33338898 | 4.05 |
ENSMUST00000119173.8
|
Slc12a8
|
solute carrier family 12 (potassium/chloride transporters), member 8 |
chr10_+_62088104 | 4.03 |
ENSMUST00000020278.6
|
Tacr2
|
tachykinin receptor 2 |
chr14_+_32321824 | 3.99 |
ENSMUST00000068938.7
ENSMUST00000228878.2 |
Prrxl1
|
paired related homeobox protein-like 1 |
chr3_+_93301003 | 3.99 |
ENSMUST00000045912.3
|
Rptn
|
repetin |
chr10_-_95678786 | 3.99 |
ENSMUST00000211096.2
|
Gm33543
|
predicted gene, 33543 |
chr1_+_34160331 | 3.96 |
ENSMUST00000183006.5
|
Dst
|
dystonin |
chr10_-_41487315 | 3.95 |
ENSMUST00000219054.2
|
Ccdc162
|
coiled-coil domain containing 162 |
chr7_+_67305162 | 3.94 |
ENSMUST00000107470.2
|
Ttc23
|
tetratricopeptide repeat domain 23 |
chr2_+_164245114 | 3.92 |
ENSMUST00000017151.2
|
Rbpjl
|
recombination signal binding protein for immunoglobulin kappa J region-like |
chr19_+_55730242 | 3.92 |
ENSMUST00000111662.11
ENSMUST00000041717.14 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr11_-_99884818 | 3.90 |
ENSMUST00000105049.2
|
Krtap17-1
|
keratin associated protein 17-1 |
chr15_+_3300249 | 3.87 |
ENSMUST00000082424.12
ENSMUST00000159158.9 ENSMUST00000159216.10 ENSMUST00000160311.3 |
Selenop
|
selenoprotein P |
chr9_+_74860133 | 3.86 |
ENSMUST00000215370.2
|
Fam214a
|
family with sequence similarity 214, member A |
chr3_-_82811269 | 3.82 |
ENSMUST00000029632.7
|
Lrat
|
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
chr3_-_24837772 | 3.81 |
ENSMUST00000203414.2
|
Naaladl2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
chr19_+_23118545 | 3.81 |
ENSMUST00000036884.3
|
Klf9
|
Kruppel-like factor 9 |
chr16_+_33338648 | 3.80 |
ENSMUST00000122427.8
ENSMUST00000059056.15 |
Slc12a8
|
solute carrier family 12 (potassium/chloride transporters), member 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.5 | 77.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
11.5 | 45.9 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
8.3 | 57.9 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
7.1 | 21.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
6.7 | 20.2 | GO:2000487 | asparagine transport(GO:0006867) positive regulation of glutamine transport(GO:2000487) |
5.6 | 78.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
5.4 | 21.7 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
4.4 | 26.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
4.4 | 22.0 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
3.6 | 21.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
3.5 | 52.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.5 | 24.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
2.9 | 17.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
2.6 | 30.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
2.5 | 12.6 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
2.3 | 21.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.3 | 72.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
2.2 | 11.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
2.2 | 6.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.2 | 10.9 | GO:0009441 | glycolate metabolic process(GO:0009441) |
2.1 | 6.4 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
2.1 | 12.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.1 | 29.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
2.1 | 27.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
2.1 | 8.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.1 | 10.4 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
2.1 | 4.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.1 | 6.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
2.0 | 12.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.0 | 12.1 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
1.9 | 5.8 | GO:0021759 | globus pallidus development(GO:0021759) |
1.9 | 15.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.9 | 11.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.8 | 12.9 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.8 | 7.1 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.8 | 17.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 27.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
1.7 | 5.0 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
1.6 | 21.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 18.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.4 | 4.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.4 | 11.3 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
1.3 | 5.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
1.2 | 67.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.2 | 5.9 | GO:0072564 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
1.2 | 36.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.2 | 9.4 | GO:0070268 | cornification(GO:0070268) |
1.2 | 10.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
1.1 | 7.9 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.1 | 3.4 | GO:1900135 | positive regulation of glomerular filtration(GO:0003104) positive regulation of eosinophil degranulation(GO:0043311) regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) positive regulation of renin secretion into blood stream(GO:1900135) positive regulation of eosinophil activation(GO:1902568) |
1.1 | 10.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.0 | 4.1 | GO:0090472 | dibasic protein processing(GO:0090472) |
1.0 | 33.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.0 | 6.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.9 | 9.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.9 | 5.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 13.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.9 | 13.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.9 | 13.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.8 | 16.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 1.6 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
0.8 | 4.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) prolactin secretion(GO:0070459) |
0.8 | 8.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.8 | 3.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 10.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 24.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.7 | 8.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 2.0 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.7 | 6.1 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 12.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.7 | 3.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 11.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.6 | 20.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.6 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 10.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.6 | 5.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 1.8 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.6 | 11.8 | GO:0051132 | NK T cell activation(GO:0051132) |
0.6 | 6.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 8.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.6 | 2.8 | GO:0036343 | psychomotor behavior(GO:0036343) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.5 | 3.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 13.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.5 | 3.7 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 24.5 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.5 | 3.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 4.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 3.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.5 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 4.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 10.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 2.2 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.4 | 2.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 3.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 4.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 3.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 3.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 2.6 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 1.5 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.4 | 6.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 1.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 2.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 1.8 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 9.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.7 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.3 | 4.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 5.5 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.3 | 6.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 3.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.6 | GO:0010157 | response to chlorate(GO:0010157) |
0.3 | 44.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 1.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 0.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 4.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 29.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.3 | 5.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 11.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 30.8 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.3 | 8.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 2.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 1.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 10.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 30.8 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 5.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 8.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 8.7 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 3.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 2.1 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.2 | 2.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.4 | GO:0051611 | regulation of serotonin uptake(GO:0051611) |
0.2 | 1.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 19.7 | GO:0007586 | digestion(GO:0007586) |
0.2 | 2.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 12.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 4.7 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 4.3 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.3 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 1.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 2.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 5.2 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 1.1 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 35.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 2.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 7.4 | GO:0044259 | collagen metabolic process(GO:0032963) multicellular organismal macromolecule metabolic process(GO:0044259) |
0.1 | 3.0 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0097156 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
0.1 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 4.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 2.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 9.5 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 1.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 10.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 2.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 2.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 2.9 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 2.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 1.2 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 5.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.9 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 4.9 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 1.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.0 | 2.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 2.5 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 2.0 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 3.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 1.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.2 | 75.6 | GO:0034359 | mature chylomicron(GO:0034359) |
8.3 | 74.6 | GO:0005579 | membrane attack complex(GO:0005579) |
5.7 | 28.7 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.6 | 10.7 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
3.1 | 15.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
3.1 | 31.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
3.0 | 29.7 | GO:0030478 | actin cap(GO:0030478) |
2.7 | 24.5 | GO:1990357 | terminal web(GO:1990357) |
2.1 | 10.4 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
1.9 | 30.2 | GO:0042627 | chylomicron(GO:0042627) |
1.4 | 10.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.4 | 15.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.3 | 36.3 | GO:0005922 | connexon complex(GO:0005922) |
1.1 | 11.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
1.1 | 19.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.0 | 22.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.9 | 5.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.9 | 2.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.8 | 11.5 | GO:0043219 | lateral loop(GO:0043219) |
0.7 | 2.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.5 | 59.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 13.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 123.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 2.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 12.0 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 10.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 4.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 4.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 12.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 16.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 43.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 27.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 8.6 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 40.3 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.2 | 65.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 8.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 3.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 6.9 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 30.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 7.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 244.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 2.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 4.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 12.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 2.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 4.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 4.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 9.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 3.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.7 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 3.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 4.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 1.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 8.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 25.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 2.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 105.8 | GO:0035473 | lipase binding(GO:0035473) |
6.8 | 27.0 | GO:1902271 | D3 vitamins binding(GO:1902271) |
5.6 | 33.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
5.2 | 15.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
5.0 | 20.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
4.9 | 39.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
4.8 | 28.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
4.3 | 21.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
4.3 | 12.9 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
4.2 | 4.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.4 | 10.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
3.3 | 13.1 | GO:0019862 | IgA binding(GO:0019862) |
3.0 | 9.0 | GO:0035375 | zymogen binding(GO:0035375) |
2.9 | 17.3 | GO:0015232 | heme transporter activity(GO:0015232) |
2.8 | 11.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.7 | 10.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.6 | 15.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.5 | 12.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
2.1 | 6.4 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
1.8 | 25.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.7 | 6.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.7 | 30.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.6 | 19.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.6 | 25.7 | GO:1990405 | protein antigen binding(GO:1990405) |
1.6 | 6.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.6 | 10.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.5 | 18.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.5 | 59.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
1.5 | 11.8 | GO:0005534 | galactose binding(GO:0005534) |
1.4 | 19.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.2 | 10.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.2 | 5.9 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
1.2 | 3.5 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
1.1 | 6.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.1 | 45.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.0 | 4.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.0 | 11.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.9 | 4.7 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.9 | 6.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.8 | 3.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.8 | 2.5 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.8 | 13.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.8 | 23.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 129.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.8 | 21.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.8 | 3.0 | GO:0005118 | sevenless binding(GO:0005118) |
0.7 | 2.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.7 | 1.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.7 | 11.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 7.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 2.1 | GO:0052597 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
0.7 | 13.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 4.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.7 | 5.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 10.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 50.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 3.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.6 | 2.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 1.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 17.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.5 | 20.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.5 | 22.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.5 | 69.1 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.5 | 8.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.5 | 1.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.5 | 2.3 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.4 | 4.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.4 | 13.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 1.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 13.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 2.9 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 2.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 6.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 6.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 31.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 9.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 4.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 15.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 43.3 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 3.9 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 16.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 3.8 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 1.6 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.2 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 6.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 6.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 2.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 1.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.2 | 2.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 2.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 2.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 2.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 36.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 3.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 5.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 3.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 12.6 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 2.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 10.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 3.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 24.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 15.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 4.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 48.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 7.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 1.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 6.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 5.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 2.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 4.2 | GO:0005525 | GTP binding(GO:0005525) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 130.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.0 | 55.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 10.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 110.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 36.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 28.8 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 30.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 10.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 9.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 11.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 80.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 21.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 21.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 20.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 8.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 9.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 14.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 8.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 9.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 5.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 5.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 121.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
4.1 | 12.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.6 | 39.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.5 | 77.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
2.3 | 47.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.2 | 50.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.6 | 36.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.5 | 62.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.4 | 91.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.2 | 22.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.1 | 27.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 15.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 15.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 13.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 10.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 7.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 8.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 29.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 23.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.5 | 18.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 5.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 16.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 20.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 3.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.5 | 4.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 21.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 6.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 8.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 6.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 2.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 1.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 10.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 2.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 9.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 10.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 22.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 12.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 5.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 22.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 6.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 43.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 3.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 2.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 6.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 4.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 5.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 4.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 9.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 3.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 1.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |